The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

被引:608
作者
Abraham, B [1 ]
Antó, JM [1 ]
Barreiro, E [1 ]
Bel, EHD [1 ]
Bonsignore, G [1 ]
Bousquet, J [1 ]
Castellsague, J [1 ]
Chanez, P [1 ]
Cibella, F [1 ]
Cuttitta, G [1 ]
Dahlén, B [1 ]
Dahlén, SE [1 ]
Drews, N [1 ]
Djukanovic, R [1 ]
Fabbri, LM [1 ]
Folkerts, G [1 ]
Gaga, M [1 ]
Gratziou, C [1 ]
Guerrera, G [1 ]
Holgate, ST [1 ]
Howarth, PH [1 ]
Johnston, SL [1 ]
Kanniess, F [1 ]
Kips, JC [1 ]
Kerstjens, HAM [1 ]
Kumlin, M [1 ]
Magnussen, H [1 ]
Nijkamp, FP [1 ]
Papageorgiou, N [1 ]
Papi, A [1 ]
Postma, DS [1 ]
Pauwels, RA [1 ]
Rabe, KF [1 ]
Richter, K [1 ]
Roldaan, AC [1 ]
Romagnoli, M [1 ]
Roquet, A [1 ]
Sanjuas, C [1 ]
Siafakas, NM [1 ]
Timens, W [1 ]
Tzanakis, N [1 ]
Vachier, I [1 ]
Vignola, AM [1 ]
Watson, L [1 ]
Yourgioti, G [1 ]
机构
[1] Southampton Gen Hosp, Resp Cell & Mol Biol Res Div, Southampton SO16 6YD, Hants, England
关键词
asthma; atopy; clinical characteristics; disease severity; inflammatory biomarkers; sex-related disease;
D O I
10.1183/09031936.03.00261903
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Since severe asthma is a poorly understood, major health problem, 12 clinical specialist centres in nine European countries formed a European Network For Understanding Mechanisms Of Severe Asthma (ENFUMOSA). In a cross-sectional observational study, a total of 163 subjects with severe asthma were compared with 158 subjects whose asthma was controlled by low doses of inhaled corticosteroids (median dose of beclomethasone equivalents 666 mug). Despite being treated with higher doses of inhaled corticosteroids; (median dose 1773 mug) and for a third of the severe asthmatics also being treated with regular, oral-steroid therapy (median daily dose 19 mg), the subjects with severe asthma met the inclusion criteria. The criteria required subjects to have undergone at least one asthma exacerbation in the past year requiring oral steroid treatment. Females dominated the severe asthma group (female/male ratio 4.4:1 versus 1.6:1 in the controlled asthmatics), and compared with controlled asthmatics, they had a predominantly neutrophilic inflammation (sputum neutrophils, 36 versus 28%) and evidence of ongoing mediator release but less atopy. From these findings and other physiological and clinical data reported in this paper, it is suggested that severe asthma might be a different form of asthma rather than an increase in asthma symptoms. The findings prompt for longitudinal studies and interventions to define the mechanisms in severe asthma.
引用
收藏
页码:470 / 477
页数:8
相关论文
共 32 条
[1]
Difficult asthma [J].
Barnes, PJ ;
Woolcock, AJ .
EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (05) :1209-1218
[2]
Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response [J].
Bryan, SA ;
O'Connor, BJ ;
Matti, S ;
Leckie, MJ ;
Kanabar, V ;
Khan, J ;
Warrington, SJ ;
Renzetti, L ;
Rames, A ;
Bock, JA ;
Boyce, MJ ;
Hansel, TT ;
Holgate, ST ;
Barnes, PJ .
LANCET, 2000, 356 (9248) :2149-2153
[3]
STANDARDIZATION OF THE MEASUREMENT OF TRANSFER-FACTOR (DIFFUSING-CAPACITY) - REPORT WORKING PARTY STANDARDIZATION OF LUNG-FUNCTION TESTS EUROPEAN-COMMUNITY FOR STEEL AND COAL - OFFICIAL STATEMENT OF THE EUROPEAN RESPIRATORY SOCIETY [J].
COTES, JE ;
CHINN, DJ ;
QUANJER, PH ;
ROCA, J ;
YERNAULT, JC .
EUROPEAN RESPIRATORY JOURNAL, 1993, 6 :41-52
[4]
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma [J].
Cowburn, AS ;
Sladek, K ;
Soja, J ;
Adamek, L ;
Nizankowska, E ;
Szczeklik, A ;
Lam, BK ;
Penrose, JF ;
Austen, KF ;
Holgate, ST ;
Sampson, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :834-846
[5]
Chronic Chlamydia pneumoniae infection and asthma exacerbations in children [J].
Cunningham, AF ;
Johnston, SL ;
Julious, SA ;
Lampe, FC ;
Ward, ME .
EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (02) :345-349
[6]
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics [J].
Dahlén, B ;
Nizankowska, E ;
Szczeklik, A ;
Zetterström, O ;
Bochenek, G ;
Kumlin, M ;
Mastalerz, L ;
Pinis, G ;
Swanson, LJ ;
Boodhoo, TI ;
Wright, S ;
Dubé, LM ;
Dahlén, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) :1187-1194
[7]
Improvement of asprinin-intolerant asthma by montelukast, a leukotriene antagonist -: A randomized, double-blink, placebo-controlled trial [J].
Dahlén, SE ;
Malmström, K ;
Nizankowska, E ;
Dahlén, B ;
Kuna, P ;
Kowalski, M ;
Lumry, WR ;
Picado, C ;
Stevenson, DD ;
Bousquet, J ;
Pauwels, R ;
Holgate, ST ;
Shahane, A ;
Zhang, J ;
Reiss, TF ;
Szczeklik, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (01) :9-14
[8]
in't Veen JCCM, 1999, AM J RESP CRIT CARE, V160, P93
[9]
Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy - Phenotype issues [J].
Kauffmann, F ;
Dizier, MH ;
Pin, I ;
Paty, E ;
Gormand, F ;
Vervloet, D ;
Bousquet, J ;
Neukirch, F ;
Annesi, I ;
Oryszczyn, MP ;
Lathrop, M ;
Demenais, F ;
Lockhart, A ;
Feingold, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (04) :S123-S129
[10]
Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma [J].
Kraft, M ;
Cassell, GH ;
Henson, JE ;
Watson, H ;
Williamson, J ;
Marmion, BP ;
Gaydos, CA ;
Martin, RJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (03) :998-1001